| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03c4720e107878f494e6eb5a8e8500ea |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
| filingDate |
2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03f6cbe8fc74c9c13fb53ce5a1572a24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b8f6e782be1893d05df66d69c888896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_490a73f7073d3af4a62731e2358e1c4e |
| publicationDate |
2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
FR-2908999-A1 |
| titleOfInvention |
NOVEL DRUG FOR THE INHIBITION, PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS. |
| abstract |
The present invention relates to the use of at least one interleukin 17F inhibitor and / or at least one IL17 receptor inhibitor, for the preparation of a medicament for inhibition, The invention also relates to a pharmaceutical composition comprising as active substance at least one interleukin 17F inhibitor and / or at least one inhibitor of an IL17 receptor in combination with a pharmaceutically appropriate carrier, as well as its use for the inhibition, prevention or treatment of rheumatoid arthritis. |
| priorityDate |
2006-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |